Planned Parenthood Played Key Role in Developing ella® Which Prevents Pregnancy Up to Five Days After Unprotected Intercourse
Planned Parenthood Federation of America applauds today’s official launch of the emergency contraception ella® in the United States. ella can be used safely and effectively up to five days after unprotected intercourse to prevent unplanned pregnancies. Planned Parenthood health providers may begin providing prescriptions of ella to patients today.
“Preventing unintended pregnancies is one of Planned Parenthood’s top priorities,” said Cecile Richards, president of Planned Parenthood Federation of America. “Today’s launch of ella in the U.S. gives American women one more option for backup birth control.”
Planned Parenthood Federation of America played an integral role in the development of ella. Per FDA protocol, clinical trials were conducted, and ella was proven to maintain its high effectiveness over five days. Several Planned Parenthood affiliates participated in these clinical trials.
In addition, Dr. Paul Fine, medical director, Planned Parenthood Gulf Coast, was lead author on a key study on the safety and effectiveness of ella in the February 2010 journal of Obstetrics and Gynecology. That study was based on the experience of 1,241 women who were patients at Planned Parenthood health centers.
Dr. Vanessa Cullins, vice president for medical affairs, Planned Parenthood Federation of America, and Dr. Paul Fine were also on hand as medical experts during last summer’s FDA hearings on ella.
“As a trusted health provider, Planned Parenthood has played a key role in the development of ella,” said Richards. “We are always looking for ways to help women prevent an unplanned pregnancy.”
To learn more about ella, please see Planned Parenthood’s Fact Sheet.
EXPERT SPOKESPERSONS AVAILABLE
To speak with Dr. Paul Fine or other medical experts regarding ella, please contact the Planned Parenthood Federation of America media office, 212-261-4433.
Planned Parenthood Federation of America media office: 212-261-4433
May 14, 2014